Welcome to our dedicated page for Churchill Cap X SEC filings (Ticker: CCCX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Churchill Capital Corp X (CCCX) files with the U.S. Securities and Exchange Commission as a blank check company listed on Nasdaq. This SEC filings page allows investors to review the company’s regulatory documents, which are central to understanding its structure as a special purpose acquisition company and its proposed business combination with ColdQuanta, Inc. (Infleqtion).
Key filings for Churchill Capital Corp X include current reports on Form 8-K, which disclose material events. One such Form 8-K describes the Agreement and Plan of Merger and Reorganization among Churchill Capital Corp X, two merger subsidiaries, and ColdQuanta, Inc., and notes the confidential submission of a draft registration statement on Form S-4. Subsequent communications reference the filing of a joint Form S-4 that includes a preliminary proxy statement/prospectus for Churchill Capital Corp X shareholders.
Through this page, users can access the company’s registration statements, proxy materials related to the proposed transaction, and other Exchange Act reports. These documents outline the terms of the business combination, the securities to be issued, and the risk factors associated with the transaction and the combined company. They also provide details on Churchill Capital Corp X’s units, Class A ordinary shares, and warrants listed on Nasdaq.
Stock Titan enhances these filings with AI-powered summaries that explain complex sections in plain language, helping readers interpret items such as merger terms, forward-looking statements, and risk disclosures. As new filings are made available through EDGAR, they are reflected here so that investors can review the latest information on CCCX, the proposed Infleqtion merger, and any subsequent corporate actions.
Use this page to examine Churchill Capital Corp X’s 8-K reports, registration statements on Form S-4, and related proxy and prospectus materials, and to understand how the company’s SPAC structure and planned business combination are documented in its official SEC submissions.
Infleqtion, Inc. is changing its independent auditor. On March 20, 2026, the Audit Committee approved the dismissal of WithumSmith+Brown, PC as auditor, effective after Withum completes the audit of the Company’s consolidated financial statements for the year ended December 31, 2025.
Withum’s prior report on Churchill Capital Corp X’s 2024 financial statements contained no adverse opinions or qualifications, and there were no disagreements or reportable events under SEC rules. The Company has requested a confirmation letter from Withum, filed as Exhibit 16.1.
The Audit Committee also approved engaging KPMG LLP as Infleqtion’s independent auditor for the year ending December 31, 2026, subject to Churchill’s 2025 Form 10-K filing and execution of an engagement letter. The Company states it did not consult KPMG on accounting or audit matters before this engagement.
Infleqtion, Inc. Schedule 13G filing reports that BOKA Group entities and John James together report 12,448,810 shares of Common Stock, representing 5.75% of the class as calculated on February 13, 2026.
The filing states these shares are held by BOKA Group Holdings I LP, with shared voting and dispositive power reported, and that the reporting persons file jointly while disclaiming beneficial ownership except to the extent of pecuniary interest.
Infleqtion, Inc. filed a Form 3 showing that investor Tyler Brous is a more than 10% beneficial owner of INFQ. The filing reports a stock option for 34,740 shares held directly; this option becomes fully exercisable only when a Form S-8 registration statement for Infleqtion becomes effective, which cannot occur before April 14, 2026.
Common shares are held indirectly through affiliated entities LCP Quantum Partners I–VI. These entities hold 14,363,414; 3,097,848; 7,796,419; 1,814,502; 2,816,731; and 640,000 Infleqtion common shares, respectively. Brous has or shares voting and investment power over these securities through related management LLCs but disclaims beneficial ownership except to the extent of his pecuniary interest.
Infleqtion, Inc. Schedule 13G discloses that Tyler Brous and affiliated LCP Quantum entities beneficially own 30,563,654 shares of Common Stock, equal to 14.1% of the class. The filing shows shared voting and dispositive power of 30,563,614 shares and notes Mr. Brous holds options exercisable for 34,740 shares. The reporting persons state they are filing jointly and expressly disclaim membership in a group. The signatures are dated 02/26/2026.
Infleqtion, Inc. reports Schedule 13G disclosures showing shared beneficial ownership stakes by Global Frontier entities and W. Grant Dollens. Global Frontier Investments, LLC (GFI) has 25,622,170 shares (11.84%); Global Frontier Quantum Opportunity Fund (GFQOF) holds 20,839,094 shares (9.63%); W. Grant Dollens is reported with 25,705,546 shares (11.87%). These percentages are calculated based on 216,471,927 shares outstanding as of February 13, 2026 as referenced in the filing.
The filing states shared voting and dispositive power for the Global Frontier entities and indicates GFQOF holds its shares for the benefit of its investors.
Infleqtion, Inc. has a new large shareholder group, as Maverick-affiliated funds filed a Schedule 13D reporting beneficial ownership of 19,976,664 common shares, or 9.2% of the company. The percentage is based on 216,471,927 shares outstanding, including options for 34,740 shares.
The Maverick entities and principals Lee S. Ainslie III and David B. Singer state they hold the position for investment purposes, funded with working capital from various Maverick funds. They may buy more or sell shares over time, and may discuss Infleqtion’s strategy and ways to maximize stockholder value with management and other stakeholders, but currently report no specific plans for major corporate actions.
Churchill Capital Corp X/Cayman received an initial Form 3 from investment adviser Maverick Capital and related reporting persons, detailing their indirect holdings of the company’s common stock and options as of February 13, 2026. The filing lists several large blocks of common stock held through Maverick-managed funds and accounts, including holdings of 9,816,912 shares and 6,217,382 shares, along with additional smaller positions in other vehicles. It also reports stock option positions labeled as a right to buy, with 34,740 and 29,950 options outstanding, tied to director compensation for David B. Singer. One third of the shares underlying these options vest on February 17, 2027, with the remainder vesting monthly thereafter, and the economic benefit of this director compensation is directed to a Maverick-related fund. Each reporting owner disclaims beneficial ownership beyond its or his pecuniary interest.
Infleqtion, Inc. director David B. Singer reported receiving two grants of stock options totaling 64,690 options. One block of 34,740 fully vested options reflects legacy ColdQuanta, Inc. awards that were automatically converted into Infleqtion options in connection with the Churchill Capital Corp X–ColdQuanta mergers and subsequent name change to Infleqtion, Inc.
The second grant covers 29,950 options tied to his board service, with one-third vesting on February 17, 2027 and the remainder vesting monthly over three years, subject to continued service. The economic benefit of his director compensation flows to Maverick Ventures Investment Fund, L.P. through a management fee offset, and Singer disclaims beneficial ownership except to the extent of his pecuniary interest.
Churchill Capital Corp X/Cayman director reports option grant tied to merger. Dawn Clawson Meyerriecks acquired stock options for 347,403 shares of Infleqtion, Inc. on February 13, 2026, at an exercise price of $0.00 per share. These options are fully vested and were received under a merger agreement dated September 8, 2025, in which Churchill Capital Corp X combined with ColdQuanta, Inc. and changed its name to Infleqtion, Inc. Legacy ColdQuanta stock options were automatically converted into options of Infleqtion with the same terms and conditions.
Infleqtion, Inc. director Kristina M. Johnson reported equity awards linked to the merger of Churchill Capital Corp X with ColdQuanta. She was granted 373,458 stock options at an exercise price of $0.00 per share, which vest monthly from June 1, 2024 in 36 equal installments, contingent on continued service.
Johnson also reported an acquisition of 33,120 shares of common stock for $0.00 per share. These shares are held indirectly by Catalyzer Ventures, LP Fund I, over which she has voting and investment power and may therefore be deemed a beneficial owner.